Additive effects of glucagon-like peptide 1 and pioglitazone in patients with type 2 diabetes.

Medicine & Life Sciences

• Appetite 18%
• Area Under Curve 7%
• Breakfast 10%
• Fasting 14%
• Glucagon 18%
• Glucagon-Like Peptide 1 92%
• Glucose 27%
• Insulin 11%
• Nonesterified Fatty Acids 18%
• Observation 6%
• Pioglitazone 100%
• Research Design 6%
• Subcutaneous Infusions 11%
• Tablets 8%
• Therapeutics 12%
• Type 2 Diabetes Mellitus 59%